899 studies found for:    Open Studies | "Hypoglycemic Agents"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Hypoglycemic Agents"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Vitamin C Supplementation Plus Hypoglycemic Agents Versus Hypoglycemic Agents Alone in Type 2 Diabetes Mellitus
Condition: Type 2 Diabetes Mellitus
Interventions: Dietary Supplement: Vitamin C;   Drug: glyburide
2 Unknown  DARE: Diabetes in cArdiac REhabilitation
Conditions: Type 2 Diabetes Mellitus;   Coronary Artery Disease
Interventions: Other: Conventional antidiabetic treatment;   Other: Intensive insulin treatment
3 Recruiting Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Type 2 Diabetes
Condition: Type 2 Diabetes
Intervention: Biological: MSC
4 Recruiting White Blood Cell Signaling and Defense Mechanisms in Patients With Diabetes Mellitus Type 2 and Periodontitis
Conditions: Chronic Periodontitis;   Diabetes Mellitus, Type 2
Interventions: Procedure: ADT+FD;   Procedure: FD
5 Recruiting Prospective Controlled Trial on Surgical Treatment of Type 2 Diabetes Patients With BMI 25-30 by Means of Biliopancreatic Diversion
Conditions: Type 2 Diabetes Mellitus;   Bariatric Surgery;   Biliopancreatic Diversion
Interventions: Procedure: biliopancreatic diversion;   Drug: antidiabetics
6 Recruiting IMS® DIAREG Diabetes Registry
Condition: Type 2 Diabetes Mellitus
Intervention: Drug: antidiabetic treatment (ATC A10B)
7 Recruiting Blood/Interstitial Glucose Measurements and Cognitive Function During Hypoglycemia and Recovery
Condition: Focus of Study is Cognitive Function During and After Hypoglycemia and to See if This Correlates Better With Blood or Interstitial Glucose Concentration.
Interventions: Procedure: euglycemic and hypoglycemic clamp;   Procedure: interstitial fluid measurement for glucose concentration;   Device: continuous glucose monitor
8 Not yet recruiting Dipeptidyl Peptidase-4 Inhibition in Psoriasis Patients With Diabetes (DIP): A Randomized Clinical Trial.
Conditions: Psoriasis;   Type 2 Diabetes Mellitus
Interventions: Drug: Sitagliptin;   Drug: Gliclazide;   Drug: Sitagliptin matched placebo;   Drug: Gliclazide matched placebo capsule
9 Recruiting Anti-diabetic Effects of Liraglutide in Adolescents and Young Subjects With Type 1 Diabetes
Condition: Type 1 Diabetes
Interventions: Drug: Liraglutide;   Drug: Placebo
10 Recruiting Oral Antidiabetic Agents in Pregnancy
Condition: Gestational Diabetes
Interventions: Drug: Metformin;   Drug: Glyburide
11 Recruiting Effects of Antidiabetic Medications on the Postprandial State in Prediabetes
Conditions: Prediabetes;   Obesity
Interventions: Drug: Exenatide;   Drug: Saxagliptin;   Drug: Pioglitazone;   Other: Placebo
12 Recruiting Effect of Anti-diabetic Drugs on Bone Metabolism and Glycemic Variability
Conditions: Type 2 Diabetes Mellitus;   Menopause;   Osteoporosis;   Osteopenia
Interventions: Drug: Vildagliptin;   Drug: Gliclazide MR
13 Recruiting Antidiabetic Effects of Adding a DPP-4 Inhibitor (Sitagliptin) to Pre-Existing Treatment With an Incretin Mimetic (Liraglutide) in Patients With Type 2 Diabetes Treated With Metformin
Condition: Type 2 Diabetes
Interventions: Drug: Sitagliptin;   Drug: Placebo;   Other: Mixed meal test;   Drug: Liraglutide
14 Recruiting Safety and Efficacy of Exenatide as Monotherapy and Adjunctive Therapy to Oral Antidiabetic Agents in Adolescents With Type 2 Diabetes
Condition: Type 2 Diabetes
Interventions: Drug: placebo;   Drug: exenatide
15 Unknown  The Anti-Diabetic and Cholesterol-Lowering Effects of Cinnamon and Cassia Bark
Conditions: Type 2 Diabetes;   Hypercholesterolemia
Interventions: Dietary Supplement: Cinnamonforce;   Dietary Supplement: Placebo
16 Recruiting Safety and Tolerability of Lixisenatide in Combination With Oral Anti-Diabetic Treatment in Patients With Type 2 Diabetes
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: lixisenatide AVE0010;   Drug: biguanide;   Drug: TZD;   Drug: alpha-GI;   Drug: glinide
17 Unknown  A Double-Blind, Randomized, Parallel, Comparative Study to Evaluate the Efficacy and Safety of an Antidiabetic Agent Repaglinide for the Treatment of Type 2 Diabetes Mellitus Patients
Condition: Diabetes Mellitus, Type 2
Intervention: Drug: Repaglinide
18 Recruiting Efficacy and Safety of Semaglutide Once-weekly Versus Exenatide ER 2.0 mg Once-weekly as add-on to 1-2 Oral Antidiabetic Drugs (OADs) in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: semaglutide;   Drug: exenatide
19 Recruiting A Study of the Efficacy and Safety of Ertugliflozin in Participants With Type 2 Diabetes Mellitus With Stage 3 Chronic Kidney Disease Who Have Inadequate Glycemic Control on Antihyperglycemic Therapy (MK-8835-001)
Condition: Type 2 Diabetes Mellitus
Interventions: Drug: Ertugliflozin;   Drug: Placebo
20 Recruiting Efficacy and Safety of Lixisenatide Versus Placebo on Top of Basal Insulin and/or Oral Antidiabetic Treatment in Older Type 2 Diabetic Patients
Condition: Type 2 Diabetes
Interventions: Drug: lixisenatide (AVE0010);   Drug: placebo

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years